US equities
|
SPCX
$166.72
▲+4.88%
NVDA
$236.83
▲+1.23%
MU
$1,063.76
▼-1.04%
TSLA
$377.53
▲+1.87%
MSFT
$526.35
▲+1.70%
SNDK
$1,713.00
▼-0.41%
INTC
$117.18
▼-1.80%
META
$745.10
▲+2.34%
SPCX
$166.72
▲+4.88%
NVDA
$236.83
▲+1.23%
MU
$1,063.76
▼-1.04%
TSLA
$377.53
▲+1.87%
MSFT
$526.35
▲+1.70%
SNDK
$1,713.00
▼-0.41%
INTC
$117.18
▼-1.80%
META
$745.10
▲+2.34%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Pressure Biosciences Inc
(OP:
PBIO
)
0.0002
UNCHANGED
Last Price
Updated: 1:24 PM EDT, Sep 28, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pressure Biosciences Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters New Contract Expected to Generate Significant 2023 Revenue, Drive Accelerated Future Growth
July 21, 2022
Via
Investor Brand Network
Topics
Cannabis
Pressure BioSciences Announces Second Contract for Toll Manufacturing of a CBD Nanoemulsion Product Using Its Proprietary Ultra Shear Technology Platform
July 21, 2022
PBI Partners with Leading Colorado Cannabis Company for Manufacture and Distribution of Novel Nano-CBD Topical Spray and Other Products, Anticipating $2 Million in 2023 Revenue Contribution
From
Pressure BioSciences Inc.
Via
AccessWire
Topics
Cannabis
Pressure BioSciences Announces Second Contract for Toll Manufacturing of a CBD Nanoemulsion Product Using Its Proprietary Ultra Shear Technology Platform
July 21, 2022
Via
ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) to Participate in Upcoming Emerging Growth Conference
July 06, 2022
Via
Investor Brand Network
Pressure BioSciences to Expand on Upcoming Release of CBD Nanoemulsion Oral Spray at July 6th Emerging Growth Conference - Annual Revenue to PBI Expected to Exceed $1M
July 06, 2022
Company Invites Investors, Analysts, and Advisors to Attend Its Real-Time, Interactive Update/Q&A Session
From
Pressure BioSciences Inc.
Via
AccessWire
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) to Present at 34th Emerging Growth Conference
July 05, 2022
Via
Investor Brand Network
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Participation in Upcoming Webinar Focused on Revolutionizing Development of Plant-Based Food Products
June 30, 2022
Via
Investor Brand Network
Pressure BioSciences to Participate in FORCE Family Office June 30th Webinar: Revolutionizing the Development of Plant-Based Food Products
June 30, 2022
Investors, Analysts, and Advisors Invited to Attend this Real-Time, Interactive Presentation/Q&A Event
From
Pressure BioSciences Inc.
Via
AccessWire
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters ‘Pivotal’ Agreement for Nanoemulsified CBD Spray for Oral Use
June 29, 2022
Via
Investor Brand Network
Pressure BioSciences Announces Contracted Production Launch for Estimated $3,000,000 of UST-Processed, Nanoemulsified CBD Spray for Oral Use
June 29, 2022
Safer Medical of Montana, a Seasoned Distributor of Wellness Products with a Focus on Veterans, Partners with PBI as Exclusive Distributor for Highly Stable and Water-Soluble CBD Oral Aerosol Product
From
Pressure BioSciences Inc.
Via
AccessWire
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Potential of UST(TM) as ‘Essential Tool in Future Beverage Development’
June 14, 2022
Via
Investor Brand Network
Global Plant Based Protein Market Expected To Reach $40 Billion by 2027
June 14, 2022
Palm Beach, FL – June 14, 2022 – FinancialNewsMedia.com News Commentary – The pandemic has considerably transformed consumer buying patterns, with a steady shift being witnessed toward health-improving...
Via
FinancialNewsMedia
Pressure BioSciences’ Ultra Shear Technology™ Positioned for Critical Enabling Role in Global $41 Billion (2027) Plant Protein Beverage Market
June 14, 2022
Recent Study Published by The Ohio State University Illuminates Unique Capabilities of PBI’s UST Platform for Optimal Formulation and Processing of New and Existing Plant Protein-based Beverages South...
Via
FinancialNewsMedia
Pressure BioSciences' Ultra Shear Technology Positioned for Critical Enabling Role in Global $41 Billion (2027) Plant Protein Beverage Market
June 14, 2022
Recent Study Published by The Ohio State University Illuminates Unique Capabilities of PBI's UST Platform for Optimal Formulation and Processing of New and Existing Plant Protein-based Beverages
From
Pressure BioSciences Inc.
Via
AccessWire
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) CEO Discusses UST(TM) Platform, Early Access Program on Stock Day Podcast
June 01, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Pressure BioSciences Discusses Launch of Early Access Program for Ultra Shear Technology for the Processing of Nanoemulsions with The Stock Day Podcast
June 01, 2022
Phoenix, Arizona--(Newsfile Corp. - June 1, 2022) - The Stock Day Podcast recently welcomed Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI"...
Via
Newsfile
Topics
Intellectual Property
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Featured in New ‘TechTalks’ Video
May 24, 2022
Via
Investor Brand Network
Emerging Technology Insider Releases New TechTalks Video Interview with Pressure BioSciences' CEO Richard T. Schumacher
May 24, 2022
SOUTH EASTON, MA / ACCESSWIRE / May 24, 2022 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" and the "Company") today announced that Emerging Technology Insider, a leading global source for business...
From
Pressure BioSciences Inc.
Via
AccessWire
Pressure BioSciences, Inc. Reports Q1 2022 Financial Results
May 19, 2022
Focused on the Successful Launch of its "Early Access Program" for the UST Platform, Company Already Negotiating with Four Potential Customers for Nanoemulsion Processing in Nutraceuticals and...
From
Pressure BioSciences Inc.
Via
AccessWire
Topics
Economy
Pressure BioSciences Signs Multi-Year Manufacturing Agreement; To Be First Product Commercially Sold Into Consumer Market Containing UST-Produced Nanoemulsion
↗
May 05, 2022
Image sourced from Unsplash This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Releases First-Quarter 2022 Financial Report, Corporate Update
May 20, 2022
Via
Investor Brand Network
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters First UST Early Access Manufacturing Agreement
May 04, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Pressure BioSciences Announces First Nanoemulsions Manufacturing Agreement Under Recently Released UST Early Access Program
↗
May 04, 2022
Company Signs Development & Manufacturing Agreement with Safer Medical of Montana for Formulation, Pilot Batches, and Commercial Production of CBD Topical Spray for Pain Reduction
Via
Benzinga
Pressure BioSciences Announces First Nanoemulsions Manufacturing Agreement Under Recently Released UST Early Access Program
May 04, 2022
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.
From
Pressure BioSciences Inc.
Via
AccessWire
Topics
Intellectual Property
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) to Participate at Upcoming Planet MicroCap Showcase
May 03, 2022
Via
Investor Brand Network
Pressure BioSciences to Present at the Planet MicroCap Showcase 2022 on May 4, 2022
May 03, 2022
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.
From
Pressure BioSciences Inc.
Via
AccessWire
SRAX (NASDAQ: SRAX) Releases Replays From 2022 Cannabis And Psychedelic Conference
↗
April 27, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Early Access Program for Use of Its Revolutionary UST(TM) Platform
April 27, 2022
Via
Investor Brand Network
Pressure BioSciences Announces Early Access Program for UST Nanoemulsion Processing
April 27, 2022
Strong Market Demand Fuels Company's Decision to Access Early Revenue Generating Opportunities for UST Processing of High Quality Nanoemulsions of Oil-Based Active Ingredients for Multiple Markets...
From
Pressure BioSciences Inc.
Via
AccessWire
InvestorNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Announces Availability of Replays from the 2022 Sequire Cannabis and Psychedelic Conference
April 26, 2022
Via
Investor Brand Network
Topics
Cannabis
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
